trans,trans-2,4-Nonadienal | CAS:5910-87-2

We serve trans,trans-2,4-Nonadienal CAS:5910-87-2 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
trans,trans-2,4-Nonadienal

Chemical Name:trans,trans-2,4-Nonadienal
CAS.NO:5910-87-2
Synonyms:trans,trans-2,4-Nonadienal
2,4-NONADIEN-1-AL
2,4-Nonadienal, (E,E)-
 
Physical and Chemical Properties:
Density 0.9±0.1 g/cm3
Boiling Point 222.4±0.0 °C at 760 mmHg
Molecular Formula C9H14O
Molecular Weight 138.207
Flash Point 85.6±0.0 °C
 
Specification:
Appearance:Yellow to red liquid
Assay:≥99.0%
 
Packing:200 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:Flavors and fragrances intermediate



Contact us for information like trans,trans-2,4-Nonadienal chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,2,4-Nonadienal, (E,E)- physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,2,4-NONADIEN-1-AL Use and application,2,4-Nonadienal, (E,E)- technical grade,usp/ep/jp grade.


Related News: The two institutes that discovered Shuanghuanglian’s alleged ability to “inhibit” the coronavirus are both state-run bodies.2-Bromo-3-chloropyridine manufacturer In addition to APIs, a variety of pharmaceutical excipients are contained in the medicine.3-Pyridylacetic Acid Hydrochloride supplier The rigosertib Pre-approval Access Program is expected to launch in first half of 2020 and will allow Inceptua to supply intravenous rigosertib within designated countries, primarily and initially concentrated in selected countries in Europe, in response to physician requests for patients with higher-risk MDS who have exhausted all available treatment options, and are not eligible for or have no access to the INSPIRE study.4-Pentylbenzeneboronic acid vendor In recent years, with the increasing number of patent medicines whose patents have expired, the variety and quantity of generic drugs have also increased rapidly, which has brought huge market opportunities to the API market and the output of APIs has continued to increase.Oligomannate, which uses extract from marine brown algae as raw material, received a conditional green light to treat mild-to-moderate level AD, the National Medical Products Administration (NMPA) said in a statement on its website late on Saturday.